![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, May 10, 2017 9:51:29 PM
I'm still a believer that the multiple myeloma study, once moved to orphan drug, will send this stock well into double digits.
I've been through stock declines before, which is why I always take my original investment out and sometimes a little more when I feel near term highs have been put in. Stock swings are tough, but good DD always prevails. Hang in there all, the real data and IP is near and so is the announcement of other uses for the cream.
Long and strong here! And congrats to flippers like Retired Early for making an amazing profit but still realizing the potential and staying long with some of his shares! Always stay in your comfort zone when investing!
GLTA
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM